Gilead Sciences (GILD): Rep. Val T. Hoyle (OR04) disclosed a sale $1K–$15K
Rep. Val T. Hoyle (OR04) disclosed a sale of Gilead Sciences in the $1K–$15K range.
- $1,001–$15,000
- Reported range · official band, not an exact amount
- 17 days
- Disclosure lag
- Traded
- Sep 23, 2025
- Disclosed
- Oct 10, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 29, 2024CongressDisclosed purchase of GILD — reported range $1,001 - $15,000
- Jul 28, 2025Insider · 1 personInsiders: 2 sales (~$1.1M)
- Jul 30, 2025FDAFDA drug approval: Biktarvy
- Aug 6, 2025Layoff notice · 4010 Ocean Ranch Blvd Oceanside CA 92056Layoff notice filed in CA: 5 employees
- Aug 15, 2025Insider · 2 peopleInsiders: 7 sales (~$3.6M)
- Aug 28, 2025InsiderCEO sold ~$1.14M of GILD shares in the open market
- Sep 15, 2025Insider · 2 peopleInsiders: 2 sales (~$625K)
- Sep 23, 2025 · this disclosureCongressDisclosed sale of GILD — reported range $1,001 - $15,000
What came next
- Sep 29, 2025Insider · 1 personInsiders: 2 sales (~$1.1M)
- Oct 15, 2025Insider · 2 peopleInsiders: 2 sales (~$649K)
- Oct 28, 2025Insider · 1 personInsiders: 2 sales (~$1.2M)
- Oct 30, 2025Company filing · Form 8-K · ResultsReported its results
- Nov 12, 2025Layoff notice · 4010 Ocean Ranch Blvd Oceanside CA 92056Layoff notice filed in CA: 17 employees
- Nov 12, 2025Insider · 1 personInsiders: 3 sales (~$6.6M)
- Nov 15, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 19 , 2025, Gilead Sciences, Inc., a Delaware corporation (the “Company”), announced that Deborah H. Telman will no longer serve as Executive Vice President, Corporate Affairs and General Counsel of the Company as of December 5, 2025.”
- Nov 17, 2025Insider · 2 peopleInsiders: 3 sales (~$3.8M)
- Nov 26, 2025InsiderDirector sold ~$357K of GILD shares in the open market
- Nov 28, 2025Insider · 3 peopleInsiders: 4 sales (~$2.2M)
- Dec 12, 2025Government · Federal Register noticeDetermination That DEMEROL (Meperidine Hydrochloride) Tablet, 100 Milligrams, and Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness
- Dec 15, 2025Insider · 2 peopleInsiders: 2 sales (~$732K)
- Dec 29, 2025InsiderCEO sold ~$1.25M of GILD shares in the open market
- Jan 15, 2026Insider · 2 peopleInsiders: 2 sales (~$746K)
- Jan 20, 2026InsiderDirector sold ~$618K of GILD shares in the open market
- Jan 21, 2026Layoff notice · 4010 Ocean Ranch Blvd Oceanside CA 92056Layoff notice filed in CA: 34 employees
How to read House Clerk periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Gilead Sciences
For Gilead Sciences, OQRO holds 47 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its GILD page.
Other recent filings by Rep. Val T. Hoyle (OR04)
- House Clerk periodic transaction report at Lpl Financial (LPLA)May 15, 2026
- House Clerk periodic transaction report at Costco (COST)Oct 10, 2025
- House Clerk periodic transaction report at Eaton Corporation (ETN)Oct 10, 2025
- House Clerk periodic transaction report at GE Aerospace (GE)Oct 10, 2025
- House Clerk periodic transaction report at Hilton Worldwide (HLT)Oct 10, 2025
The full history of Rep. Val T. Hoyle (OR04) is on the profile page.
How this filing works
Explore the data
Common questions
Which member of Congress traded Gilead Sciences (GILD) stock, and how much?
Rep. Val T. Hoyle (OR04) disclosed a sale of Gilead Sciences in the $1K–$15K range. Reported range, not an exact amount, Spouse account.
When did it happen, and when was it made public?
Traded: Sep 23, 2025. Disclosed: Oct 10, 2025. That is 17 days between the two dates.
Why is the amount a range and not an exact figure?
Members of Congress report each trade in a bracket set by law ($1,001 to $15,000, $15,001 to $50,000, and so on), never an exact amount. OQRO keeps the bracket as filed and does not estimate a figure inside it.
Where does this information come from?
From the House Clerk periodic transaction report, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Gilead Sciences recently?
For Gilead Sciences, OQRO holds 47 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the GILD page.
Does this mean GILD stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Gilead Sciences
- SEC Form 4Nov 18, 2026
- SEC Form 4Nov 18, 2026
- SEC Form 4Nov 18, 2026
- SEC Form 4Nov 18, 2026
- SEC Form 13F-HRNov 16, 2026
- SEC Form 144Nov 16, 2026
Everything OQRO holds on this company is on its GILD page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
